Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00228696

National Wilm's Tumor Study Late Effects

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The Late Effects Study is being conducted in order to answer scientific questions and to serve as a resource for Wilms tumor patients and their families. Patients must have been enrolled on the NWTS-5 protocol in order to be eligible for this study.

Detailed description

The Late Effects Study is being conducted in order to answer scientific questions and to serve as a resource for Wilms tumor patients and their families. Although most people in this study enjoy good health, some may be at risk for certain health conditions. We are collecting information from as many participants as possible in order to determine if they or their offspring are at risk for adverse medical conditions. If there is more than one case of Wilms tumor in a given family, we plan to work with geneticists to try to estimate heritability and recurrence risks.

Conditions

Interventions

TypeNameDescription
OTHERnone, screening onlyScreening protocol with no intervention

Timeline

Start date
2005-09-01
Primary completion
2010-12-01
Completion
2011-12-01
First posted
2005-09-29
Last updated
2013-11-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00228696. Inclusion in this directory is not an endorsement.